EUVIMEDEUVIMED entdecken
Crossref

The Art of Dodging Bullets: How Covid-19 Drug Manufacturers and Providers Plan to Escape Tort Liability

Ruan Meintjes

SMU Science and Technology Law Review · 01.01.2021 · 24 (1) · 113

DOI: 10.25172/smustlr.24.1.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SMU Science and Technology Law Review, online erschienen am 01.01.2021. Verfasst von Ruan Meintjes.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prior to his time at SMU, Ruan served as the Chief Operating Officer at a specialty healthcare company in North Texas where he oversaw the company's clinical, surgical, laboratory, and research divisions.Outside of school, Ruan enjoys spending time with his wife

Zitieren

APA

Meintjes, R. (2021). The Art of Dodging Bullets: How Covid-19 Drug Manufacturers and Providers Plan to Escape Tort Liability. SMU Science and Technology Law Review, 24(1), 113. https://doi.org/10.25172/smustlr.24.1.5

Vancouver

Meintjes R. The Art of Dodging Bullets: How Covid-19 Drug Manufacturers and Providers Plan to Escape Tort Liability. SMU Science and Technology Law Review. 2021;24(1):113. doi:10.25172/smustlr.24.1.5

BibTeX
@article{Meintjes2021,
  author = {Meintjes, Ruan},
  title = {The Art of Dodging Bullets: How Covid-19 Drug Manufacturers and Providers Plan to Escape Tort Liability},
  journal = {SMU Science and Technology Law Review},
  year = {2021},
  volume = {24},
  number = {1},
  pages = {113},
  doi = {10.25172/smustlr.24.1.5}
}
Kostenlos starten →